U.S. FDA Clears EkoSonic® Endovascular System for Treatment of Pulmonary Embolism

EKOS Corporation has gained U.S. FDA clearance to market its EkoSonic® Endovascular System for the ultrasound-facilitated, controlled and selective infusion of physician-specified fluids, including thrombolytics, into the vasculature for the treatment of pulmonary embolism (PE).

FDA Clears Covidien’s Puritan Bennett™ 980 Ventilator

Covidien plc has announced its Puritan Bennett™ 980 ventilator has received U.S. FDA 510(k) clearance. The company says its new acute care ventilator is designed to be simple, safe and smart and to enable patients to breathe more naturally than with conventional mechanical ventilators.

Cook Medical Claims First with EchoTip® ProCore™ Endobronchial Ultrasound Needle with Biopsy Capability

Cook Medical’s EchoTip® ProCore™ Endobronchial Ultrasound Needle gives physicians the ability to retrieve both cell and tissue samples from lymph nodes or tumors in the pulmonary area.

Medtronic’s Valiant Captivia Stent Graft Now FDA Approved for Aortic Dissections

Medtronic has taken the opportunity presented by this weeks Thoracic Society meeting to announce that it has gained U.S. FDA approval for its Valiant Captivia Thoracic Stent Graft System to be used in the treatment of type B aortic dissections.

Study Says Digital Chest Drains Shorten Stay and In-dwelling Chest Tube Duration

A new study, presented at the 50th holding of the Society of Thoracic Surgeons in Orlando Florida this week, points to improved management of patients when employing digital chest drains, as compared with traditional methods.

Bigging Up the World’s Smallest CPAP machine

Human Design Medical, LLC is about to release the most versatile cpap device ever. The company says its Z1™ is a new innovative cpap device that is significantly lighter, smaller, quieter and more integrated than other cpap machines and is changing the rules of design, portability and user experience in the cpap industry.

Covidien’s New Clinical Data is a Statement of Intent for its Peripheral Arterial Disease Business

Covidien has released positive final results from its DURABILITY II study and promising preliminary data from its DEFINITIVE AR Peripheral Artery Disease (PAD) trial involving some of its technologies. The results are sure to fuel its ongoing push into the peripheral vascular therapy area.

First for Gore as FDA Approves Prosthesis for Endovascular Repair of Aortic Dissection

W. L. Gore & Associates has gained FDA approval for its Conformable GORE® TAG® Thoracic Endoprosthesis for endovascular repair of acute and chronic Type B dissections of the descending thoracic aorta. This durable endoprosthesis is the only device to receive FDA approval for this indication and is designed for multiple thoracic etiologies.

European Clot Management Device Market To Exceed $170 Million By 2022

According to global market intelligence company Millennium Research Group, the European market for clot management devices will see moderate growth through 2022. Although a number of segments are mature, fast-growing segments such as endovascular treatments for acute ischemic stroke and venous thromboembolism underpin the growth forecast.

Most read

Latest

^